Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Average Weight Loss in the Orforglipron phase 3 ATTAIN-1 Trial Across the 72-week study period, participants: Lost up to 15% of their body weight at the highest dose At 36 mg: 54.6% lost 10%, 36.0% lost 15%, 18.4% lost 20% body weight (all higher than placebo)
Inositol is a type of sugar
Not for use in animals, humans, or diagnostic procedures
This early injection can cause a temporary spike in medication concentration, increasing the likelihood of gastrointestinal side effects like nausea, vomiting, or abdominal discomfort
US$ 21.19
US$ 24.30
US$ 22.11
US$ 29.71
US$ 23.19
US$ 26.44
